GlycoMimetics (GLYC) SEC Filings & 10K Form → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free GLYC Stock Alerts $0.27 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Recent GlycoMimetics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/02/20247:30 AMGlycoMimetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/01/20243:30 PMGlycoMimetics (Issuer)Koenig Scott (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/01/20247:25 AMGlycoMimetics (Filer)Form DEF 14A04/01/20247:30 AMGlycoMimetics (Filer)Form ARS03/27/20248:00 AMGlycoMimetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/27/20247:25 AMGlycoMimetics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/22/20244:00 PMGlycoMimetics (Filer)Form PRE 14A03/01/20248:16 AMGlycoMimetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/29/20246:28 PMGlycoMimetics (Subject)NEW ENTERPRISE ASSOCIATES 10 L P (Filed by)Form SC 13D/A02/09/20244:03 PMArtal International S.C.A. (Filed by)GlycoMimetics (Subject)Form SC 13G/A01/29/20243:31 PMBIOTECHNOLOGY VALUE FUND L P (Filed by)GlycoMimetics (Subject)Form SC 13G/A11/03/20237:31 AMGlycoMimetics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/03/20237:35 AMGlycoMimetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/25/20233:21 PMGlycoMimetics (Issuer)Rock Edwin (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/02/20237:30 AMGlycoMimetics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/02/20237:35 AMGlycoMimetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: Lantern Pharma 10Q Form Celularity 10Q Form Viveon Health Acquisition 10Q Form MediciNova 10Q Form Checkpoint Therapeutics 10Q Form Rallybio 10Q Form Affimed 10Q Form Leap Therapeutics 10Q Form Mural Oncology 10Q Form Immix Biopharma 10Q Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:GLYC) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWho are Nvidia’s New Silent Partners?Weiss Ratings[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
